Deprescribing: An umbrella review [PDF]
Acta PharmaceuticaThis umbrella review examined systematic reviews of deprescribing studies by characteristics of intervention, population, medicine, and setting. Clinical and humanistic outcomes, barriers and facilitators, and tools for deprescribing are presented.
Japelj Nuša +3 more
doaj +3 more sources
Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist-led deprescribing in care homes [PDF]
, 2022 The English National Overprescribing Review identified that older people often take eight or more medicines a day. The report recommended pharmacists in primary care should take responsibility for addressing polypharmacy.
Jeanette Blacklock (11516339) +7 more
core +8 more sources
“I think deprescribing is very needed in our society:” Healthcare Professional Students Perceptions of Deprescribing Education [PDF]
INNOVATIONS in PharmacyIntroduction: Deprescribing is a complex and pivotal process in the healthcare system that requires the involvement of different healthcare professionals as well as patients and family members. Given the multifaceted healthcare professionals involved in
Alina Cernasev +6 more
doaj +1 more source
Deprescribing practice in a resource-limited setting: Healthcare providers' insights
, 2021 Aims: Inappropriate polypharmacy poses risks of adverse drug events, high healthcare costs and mortality. Deprescribing could minimise inappropriate polypharmacy and the consequences thereof.
Elias, Asrat +5 more
core +1 more source
Deprescribing: future directions for research
, 2021 A World Café workshop was held at the Bruyère Evidence-Based Deprescribing Guidelines Symposium in March 2018 with 30 participants (researchers, clinicians, policy makers, stakeholders).
James Conklin (5456549) +9 more
core +3 more sources
Reducing inappropriate polypharmacy: the process of deprescribing [PDF]
, 2015 Inappropriate polypharmacy, especially in older people, imposes a substantial burden of adverse drug events, ill health, disability, hospitalization, and even death.
Page, Amy +17 more
core +1 more source
Factors Important to Older Adults Who Disagree With a Deprescribing Recommendation. [PDF]
, 2023 IMPORTANCE Little is known about why older adults decline deprescribing recommendations, primarily because interventional studies rarely capture the reasons.
Shang, Jenny +4 more
core +2 more sources
Reasons why older adults in three countries agreed with a deprescribing recommendation in a hypothetical vignette. [PDF]
, 2023 The purpose of this study was to examine factors important to older adults who agreed with a deprescribing recommendation given from a General Practitioner (GP) to a hypothetical patient experiencing polypharmacy.
Shang, Jenny +13 more
core +3 more sources
The role of pharmacists in deprescribing benzodiazepines: A scoping review
Exploratory Research in Clinical and Social Pharmacy, 2023 Background: Polypharmacy can increase the risk of adverse drug events, hospitalisation, and unnecessary healthcare costs. Evidence indicates that discontinuing certain medications, such as benzodiazepines, can improve health outcomes, by resolving ...
Fatemah Zakariya Ashkanani +2 more
doaj +1 more source
The attitudes and beliefs of doctors towards deprescribing medications
Proceedings of Singapore Healthcare, 2018 Background: The effects of polypharmacy and its related adverse outcomes are well documented among elderly patients. Deprescribing is now recognised as an important part of medication review in addressing polypharmacy.
Krithikaa Nadarajan +3 more
doaj +1 more source